Clinical Trial Update: the Effects of YangXinShi (YXS) on the Quality of Life and Exercise Tolerance in Patients With Chronic Heart Failure [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update examines the effects of YangXinShi (YXS) on quality of life and exercise tolerance in patients with chronic heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• YangXinShi

Snippet

Sponsor: Dalian University | Conditions: Chronic Heart Failure | Phase 1 | Status: UNKNOWN